PMC:7228307 / 63-384 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"22","span":{"begin":101,"end":106},"obj":"Species"}],"attributes":[{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":183,"end":197},"obj":"Body_part"},{"id":"T3","span":{"begin":198,"end":203},"obj":"Body_part"},{"id":"T4","span":{"begin":199,"end":201},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":58,"end":60},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0020320"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":3,"end":4},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":30,"end":32},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T5","span":{"begin":101,"end":106},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T6","span":{"begin":132,"end":134},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T7","span":{"begin":220,"end":228},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T8","span":{"begin":242,"end":243},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":165,"end":172},"obj":"Chemical"},{"id":"T2","span":{"begin":204,"end":211},"obj":"Chemical"},{"id":"T3","span":{"begin":293,"end":301},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_52214"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T1","span":{"begin":183,"end":197},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T2","span":{"begin":199,"end":201},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A1","pred":"meddra_id","subj":"T1","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"},{"id":"A2","pred":"meddra_id","subj":"T2","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T2","span":{"begin":277,"end":281},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"},{"id":"T3","span":{"begin":302,"end":311},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"22","span":{"begin":101,"end":106},"obj":"Species"}],"attributes":[{"id":"A22","pred":"pubann:denotes","subj":"22","obj":"Tax:9606"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T1","span":{"begin":101,"end":106},"obj":"Species"}],"attributes":[{"id":"A1","pred":"ncbi_taxonomy_id","subj":"T1","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T2","span":{"begin":30,"end":57},"obj":"Sentence"},{"id":"T3","span":{"begin":58,"end":77},"obj":"Sentence"},{"id":"T4","span":{"begin":79,"end":87},"obj":"Sentence"},{"id":"T5","span":{"begin":88,"end":96},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T2","span":{"begin":183,"end":197},"obj":"Body_part"},{"id":"T3","span":{"begin":198,"end":203},"obj":"Body_part"},{"id":"T4","span":{"begin":199,"end":201},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}

{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":30,"end":57},"obj":"Sentence"},{"id":"T3","span":{"begin":58,"end":77},"obj":"Sentence"},{"id":"T4","span":{"begin":79,"end":87},"obj":"Sentence"},{"id":"T5","span":{"begin":88,"end":96},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"y: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are "}